Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
peer-reviewed.gif (582 bytes)
eid_header.gif (2942 bytes)
second_navbar.gif (585 bytes)
 
Research

Lack of Evidence of Endogenous Avian Leukosis Virus and Endogenous Avian Retrovirus Transmission to Measles Mumps Rubella Vaccine Recipients

Althaf I. Hussain,* Vedapuri Shanmugam,* William M. Switzer,* Shirley X. Tsang,* Aly Fadly,† Donald Thea,‡ Rita Helfand,* William J. Bellini,* Thomas M. Folks,* and Walid Heneine*
*Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Avian Disease and Oncology Laboratory, U.S. Department of Agriculture, East Lansing, Michigan, USA; ‡Harvard Institute for International Development, Cambridge, Massachusetts, USA


Figure 3. Reverse transcriptase-polymerase chain reaction analysis of sera from measles mumps rubella (MMR) vaccine recipients for the presence of avian leukosis virus (ALV).

Back to article

Figure 3. Reverse transcriptase-polymerase chain reaction analysis of sera from measles mumps rubella (MMR) vaccine recipients for the presence of avian leukosis virus (ALV) (A) and endogenous avian retrovirus (EAV) (B) RNA. Lanes 1-10, samples from MMR vaccine recipients. NC, negative control, uninfected human serum; PC, positive control, culture supernatant from Rous-associated virus 0 (RAV-0) infected 15B1 chick embryo fibroblasts.
 


Home
|
Top of Page | Current Issue | Expedited | Upcoming Issue | Past Issue | EID Search | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed February 20, 2001

Emerging Infectious Diseases Journal
National Center for Infectious Diseases
Centers for Disease Control and Prevention